Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 54.6B 8.12B 6.96B 6.51B 5.95B 11.23B 778B 11.35B 77.05B 29.96B 391B 30.49B 29.83B 1,292B | P/E 2026 * |
41.8x | P/E 2027 * | 31.9x |
|---|---|---|---|---|---|
| Enterprise Value | 50.22B 7.47B 6.4B 5.99B 5.47B 10.33B 715B 10.44B 70.86B 27.55B 359B 28.04B 27.44B 1,188B | EV / Sales 2026 * |
6.22x | EV / Sales 2027 * | 5.23x |
| Free-Float |
61.13% | Yield 2026 * |
0.81% | Yield 2027 * | 1.15% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 17/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8.12B | |
| +0.79% | +2.01% | +79.83% | +125.84% | 1,111B | |
| +0.40% | +0.23% | +52.31% | +63.46% | 658B | |
| +0.31% | +2.14% | +27.42% | +80.28% | 467B | |
| +0.82% | +3.21% | +43.32% | +43.71% | 369B | |
| +0.94% | +1.59% | +26.00% | +42.18% | 301B | |
| +2.19% | +4.56% | +3.98% | +15.80% | 256B | |
| +0.15% | +4.13% | +53.52% | +72.74% | 240B | |
| +2.71% | +3.51% | -16.49% | -52.00% | 207B | |
| +0.81% | +1.95% | +28.10% | +90.26% | 182B | |
| Average | +0.89% | +4.49% | +33.11% | +53.58% | 421.22B | |
| Weighted average by Cap. | +0.81% | +4.68% | +46.25% | +72.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.07B 1.2B 1.03B 962M 880M 1.66B 115B 1.68B 11.39B 4.43B 57.72B 4.51B 4.41B 191B | 9.72B 1.45B 1.24B 1.16B 1.06B 2B 138B 2.02B 13.72B 5.33B 69.52B 5.43B 5.31B 230B |
| Net income | 1.35B 201M 172M 161M 147M 277M 19.2B 280M 1.9B 740M 9.64B 753M 737M 31.9B | 1.75B 260M 223M 209M 191M 360M 24.94B 364M 2.47B 961M 12.52B 978M 957M 41.44B |
| Net Debt | -4.39B -652M -559M -523M -478M -902M -62.48B -912M -6.19B -2.41B -31.37B -2.45B -2.4B -104B | -3.78B -563M -482M -451M -412M -778M -53.86B -786M -5.34B -2.08B -27.05B -2.11B -2.07B -89.49B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
